Firms Awarded Big Fees In Biovail Securities Case
Biovail, Canada's largest pharmaceutical company, settled the long-running class action lawsuit in December. The case was brought against the Toronto-based company in the U.S. District Court for the Southern District of New York.
"The settlement is approved as fair, reasonable and adequate, and the class members and the parties are directed to...
To view the full article, register now.